Literature DB >> 22777619

(1)H MR spectroscopy with external reference solution at 1.5 T for differentiating malignant and benign breast lesions: comparison using qualitative and quantitative approaches.

Waka Mizukoshi1, Eito Kozawa, Kaiji Inoue, Naoko Saito, Naoko Nishi, Toshiaki Saeki, Fumiko Kimura.   

Abstract

OBJECTIVE: To compare the diagnostic capability of proton ((1)H) magnetic resonance spectroscopy (MRS) in differentiating benign from malignant breast lesions on the basis of qualitative and quantitative approaches.
METHODS: We performed single-voxel (1)H MRS for 208 breast lesions, identified a clear total composite choline compounds (tCho) peak of signal-to-noise of ≥2 to represent malignancy (qualitative approach), and regarded tCho concentration equal to or greater than the cut-off value to represent malignancy (quantitative approach). We compared the diagnostic ability of both approaches using the Akaike information criterion (AIC) and McFadden's R (2).
RESULTS: Histologically, 169 lesions were malignant; 39 were benign. The qualitative approach demonstrated 84.6 % sensitivity and 51.3 % specificity for differentiating malignant and benign lesions. The mean tCho concentration was 1.13 mmol/kg for malignancy, 0.43 mmol/kg for benignity. The optimal cut-off point was 0.61 mmol/kg, use of which achieved 68.1 % sensitivity and 79.4 % specificity. Calculated AIC and R (2) score suggested the superiority of the quantitative approach for differentiating malignancy.
CONCLUSIONS: Quantitative MRS provides higher specificity than qualitative MRS for differentiating malignant from benign lesions and could be more useful as an additional examination in routine breast MR imaging.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22777619     DOI: 10.1007/s00330-012-2555-6

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  38 in total

1.  Diagnostic performance of ADC for Non-mass-like breast lesions on MR imaging.

Authors:  Tsugumi Imamura; Ichiro Isomoto; Eijun Sueyoshi; Hiroshi Yano; Tatsuya Uga; Kuniko Abe; Tomayoshi Hayashi; Sumihisa Honda; Takuma Yamaguchi; Masataka Uetani
Journal:  Magn Reson Med Sci       Date:  2010       Impact factor: 2.471

Review 2.  Dynamic contrast-enhanced breast MR imaging.

Authors:  Marianne Moon; Daniel Cornfeld; Jeffrey Weinreb
Journal:  Magn Reson Imaging Clin N Am       Date:  2009-05       Impact factor: 2.266

Review 3.  Role of magnetic resonance imaging in evaluating the extent of disease.

Authors:  Sara C Gavenonis; Susan Orel Roth
Journal:  Magn Reson Imaging Clin N Am       Date:  2010-05       Impact factor: 2.266

4.  The variability of fibroadenoma in contrast-enhanced dynamic MR mammography.

Authors:  U Brinck; U Fischer; M Korabiowska; M Jutrowski; A Schauer; E Grabbe
Journal:  AJR Am J Roentgenol       Date:  1997-05       Impact factor: 3.959

5.  Predicting pathological response to neoadjuvant chemotherapy in breast cancer with quantitative 1H MR spectroscopy using the external standard method.

Authors:  Mitsuhiro Tozaki; Masaaki Sakamoto; Yu Oyama; Katsuya Maruyama; Eisuke Fukuma
Journal:  J Magn Reson Imaging       Date:  2010-04       Impact factor: 4.813

6.  Characterization of neoplastic and normal human breast tissues with in vivo (1)H MR spectroscopy.

Authors:  K A Kvistad; I J Bakken; I S Gribbestad; B Ehrnholm; S Lundgren; H E Fjøsne; O Haraldseth
Journal:  J Magn Reson Imaging       Date:  1999-08       Impact factor: 4.813

7.  Evaluation of 1H-magnetic resonance spectroscopy of breast cancer pre- and postgadolinium administration.

Authors:  Bonnie N Joe; Victoria Y Chen; Nouha Salibi; Pornpim Fuangtharntip; Charles F Hildebolt; Kyongtae T Bae
Journal:  Invest Radiol       Date:  2005-07       Impact factor: 6.016

8.  Usefulness of diffusion-weighted imaging of breast tumors: quantitative and visual assessment.

Authors:  Kaiji Inoue; Eito Kozawa; Waka Mizukoshi; Junji Tanaka; Toshiaki Saeki; Takaki Sakurai; Fumiko Kimura
Journal:  Jpn J Radiol       Date:  2011-07-24       Impact factor: 2.374

9.  Specificity of choline metabolites for in vivo diagnosis of breast cancer using 1H MRS at 1.5 T.

Authors:  Peter Stanwell; Laurence Gluch; David Clark; Boguslaw Tomanek; Luke Baker; Bruno Giuffrè; Cynthia Lean; Peter Malycha; Carolyn Mountford
Journal:  Eur Radiol       Date:  2004-09-03       Impact factor: 5.315

10.  Assessing asthma control in UK primary care: use of routinely collected prospective observational consultation data to determine appropriateness of a variety of control assessment models.

Authors:  Gaylor Hoskins; Brian Williams; Cathy Jackson; Paul D Norman; Peter T Donnan
Journal:  BMC Fam Pract       Date:  2011-09-29       Impact factor: 2.497

View more
  9 in total

1.  Diffusion-Weighted Imaging-guided MR Spectroscopy in Breast Lesions using Readout-Segmented Echo-Planar Imaging.

Authors:  Kun Sun; Weimin Chai; Caixia Fu; Ying Zhan; Kunwei Shen; Xianfu Luo; Fuhua Yan
Journal:  Eur Radiol       Date:  2015-09-19       Impact factor: 5.315

2.  Influence of calcium on choline measurements by 1H MR spectroscopy of thigh muscles.

Authors:  Pedro A Gondim Teixeira; Gabriela Hossu; François Kauffmann; Anou Sewonu; Jean-Marc Constans; Alain Blum; Jacques Felblinger
Journal:  Eur Radiol       Date:  2014-03-16       Impact factor: 5.315

3.  Differential diagnosis between malignant and benign breast lesions using single-voxel proton MRS: a meta-analysis.

Authors:  Dongzhi Cen; Li Xu
Journal:  J Cancer Res Clin Oncol       Date:  2014-03-06       Impact factor: 4.553

4.  In vivo post-contrast 1H-MRS evaluation of malignant and benign breast lesions: a meta-analysis.

Authors:  Jieying Tan; Li Xu; Wenqing Yao; Yun Wan; Shuqin Zhou; Sherman Xuegang Xin
Journal:  Tumour Biol       Date:  2014-09-27

5.  1H-MR spectroscopy of suspicious breast mass lesions at 3T: a clinical experience.

Authors:  Stefania Montemezzi; Carlo Cavedon; Lucia Camera; Gabriele Meliadò; Francesca Caumo; Ilaria Baglio; Francesco Sardanelli
Journal:  Radiol Med       Date:  2016-12-15       Impact factor: 3.469

Review 6.  Proton MR spectroscopy in the breast: Technical innovations and clinical applications.

Authors:  Reza Fardanesh; Maria Adele Marino; Daly Avendano; Doris Leithner; Katja Pinker; Sunitha B Thakur
Journal:  J Magn Reson Imaging       Date:  2019-03-07       Impact factor: 4.813

7.  1H-MRS evaluation of breast lesions by using total choline signal-to-noise ratio as an indicator of malignancy: a meta-analysis.

Authors:  Xin Wang; Xiang Jiang Wang; Hui Sheng Song; Long Hua Chen
Journal:  Med Oncol       Date:  2015-04-21       Impact factor: 3.064

8.  Optical imaging for monitoring tumor oxygenation response after initiation of single-agent bevacizumab followed by cytotoxic chemotherapy in breast cancer patients.

Authors:  Shigeto Ueda; Ichiei Kuji; Takashi Shigekawa; Hideki Takeuchi; Hiroshi Sano; Eiko Hirokawa; Hiroko Shimada; Hiroaki Suzuki; Motoki Oda; Akihiko Osaki; Toshiaki Saeki
Journal:  PLoS One       Date:  2014-06-06       Impact factor: 3.240

Review 9.  In vivo MR spectroscopy for breast cancer diagnosis.

Authors:  Uma Sharma; Naranamangalam Raghunathan Jagannathan
Journal:  BJR Open       Date:  2019-07-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.